Promises
2 promises
Promise Tracker
1 delivered, 1 close, 0 missed.
View Promises →
Hindustan Unilever Ltd — Q4 FY26
HUL delivered 8% revenue growth in Q4 FY26, the highest in 12 quarters, driven by 7% underlying sales growth led by volumes.
bullish
high
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
HUL delivered 8% revenue growth in Q4 FY26, the highest in 12 quarters, driven by 7% underlying sales growth led by volumes. EBITDA margin at 23.7% came at the higher end of guidance, with PAT before exceptional items at ₹2,711 crore (+4% YoY). Growth was broad-based across segments, with home care and beauty & well-being leading. Management highlighted strong execution in quick commerce, premiumization in personal care, and a turnaround in lifestyle nutrition. For FY27, they expect better performance than FY26 despite geopolitical volatility and input cost inflation of 8-10%. Medium-term margin guidance remains 22.5-23.5%. Key risk: sustained crude inflation and currency depreciation could pressure margins and require further pricing actions.
Promises1 met · 0 missedRisks4 trackedTranscriptfull text
Research workspace
Focused Modules
Risks
4 risks
Risk Intelligence
Sustained crude inflation and currency depreciation
View Risks →
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
Underlying Volume Growth (UVG)
6%
+6pp YoY
Highest quarterly volume growth in 12 quarters, driven by market development and channel expansion.
Liquids Portfolio Turnover
₹4,000 Cr
+double-digit YoY
Home care liquids crossed ₹4,000 crore turnover, gaining market share through format innovation.
Beauty & Well-being ARR
₹1,200 Cr
+quadrupled YoY
Beauty and well-being portfolio quadrupled over the last year, now at ₹1,200 crore annual run rate.
Body Wash Market Share Gain
400 bps
+400bps YoY
Body wash gained 400 basis points market share, driven by premiumization and market development.
What Changed vs Last Quarter
NEW
Medium-term EBITDA margin guidance 22.5-23.5%
Margin guidance maintained at 22.5-23.5% for the medium term, with flexibility to operate at lower end if cost pressures persist.
NEW
Price increases of 2-5% already taken
Calibrated price increases of 2-5% implemented across home care and personal care to offset input cost inflation.
NEW
₹2,000 crore capex in premium formats
Capital investment of ₹2,000 crore planned for expanding capacity in premium formats across home care, personal care, and beauty.
UPDATED
FY27 to be better than FY26
Management expects FY27 performance to exceed FY26, driven by portfolio transformation and execution improvements.
DROPPED
EBITDA margin to stay in 22-23% range
Consolidated EBITDA margin will remain within the guided range of 22-23% (excluding ice cream), as growth investments are prioritized.
DROPPED
Low single-digit price increases expected over FY27
Calibrated price increases across portfolio, especially in home care, to offset input cost inflation.
NEW RISK
Sustained crude inflation and currency depreciation
Crude-linked commodity costs and rupee depreciation could increase input costs beyond current 8-10% inflation, pressuring margins.
NEW RISK
El Niño impact on rural demand
Below-normal monsoon forecast (92%) could affect rural incomes and demand, though reservoir levels and MSPs provide some buffer.
NEW RISK
Competitive intensity limiting pricing power
If competitors do not follow price hikes, HUL may need to absorb cost inflation or lose market share, potentially impacting margins.
NEW RISK
Mass skincare portfolio drag
Mass skincare (Glow & Lovely, talcum powders) remained subdued, weighing on overall beauty segment growth despite premium strength.
RISK GONE
Input cost volatility and currency depreciation
Depreciating rupee and divergent commodity trends (palm oil, tea, crude derivatives) could pressure margins if price increases lag.
RISK GONE
Competitive pressure in home care pricing
Home care pricing has been negative for an extended period due to competitive intensity; recovery may be gradual.
RISK GONE
Skincare growth lagging behind premium platforms
Analyst noted HUL's skincare growth is meaningfully lower than platforms like Nykaa; management attributed to portfolio breadth but did not quantify gap.
RISK GONE
GST transition impact on volumes
October saw destocking due to GST 2.0 rollout; while November restocked, any future policy changes could disrupt volumes.
🤫 Topics management stopped discussing
Mentioned in Q1 FY26, Q2 FY26, Q3 FY25, Q3 FY26, Q4 FY25
Calibrated price increases across portfolio, especially in home care, to offset input cost inflation.
Mentioned in Q1 FY25, Q2 FY25, Q3 FY25, Q4 FY25
Inflation in palm oil, tea, and coffee not fully priced in, while deflation in crude oil is passed on quickly, creating a price-cost gap.
Mentioned in Q2 FY26, Q3 FY25, Q3 FY26
Consolidated EBITDA margin will remain within the guided range of 22-23% (excluding ice cream), as growth investments are prioritized.
Mentioned in Q1 FY26, Q2 FY26, Q3 FY25
Ice cream demerger expected to complete in December quarter, with listing in Q4 FY26, subject to regulatory approvals.
Mentioned in Q1 FY25, Q1 FY26
Management acknowledged price decreases in home care due to both commodity deflation and competitive pressures, which could pressure margins and pricing power.
Fast read
Guidance and risk preview
Management expects FY27 performance to exceed FY26, driven by portfolio transformation and execution improvements.
Crude-linked commodity costs and rupee depreciation could increase input costs beyond current 8-10% inflation, pressuring margins.
View Risks →